Latest Insider Transactions at Fortress Biotech, Inc. (FBIO)
This section provides a real-time view of insider transactions for Fortress Biotech, Inc. (FBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Fortress Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Fortress Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
David Jin Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,625
+1.08%
|
$2,625
$1.23 P/Share
|
|
Sep 23
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
763,359
+17.27%
|
$763,359
$1.84 P/Share
|
|
Jul 11
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
5,000
+3.77%
|
$35,000
$7.48 P/Share
|
|
Jul 10
2024
|
David Jin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+50.0%
|
$3,500
$7.5 P/Share
|
|
Jul 09
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
5,000
+3.92%
|
$35,000
$7.39 P/Share
|
|
Jul 08
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
5,000
+4.08%
|
$35,000
$7.35 P/Share
|
|
Jun 28
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
20,000
+0.69%
|
$20,000
$1.64 P/Share
|
|
May 20
2024
|
Dov Klein Director |
SELL
Open market or private sale
|
Direct |
10,000
-15.77%
|
$10,000
$1.89 P/Share
|
|
May 16
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
10,000
+0.35%
|
$10,000
$1.76 P/Share
|
|
Apr 01
2024
|
David Jin Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,352
+0.98%
|
$2,352
$1.7 P/Share
|
|
Jan 05
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
50,000
+1.72%
|
$100,000
$2.38 P/Share
|
|
Jan 01
2024
|
Lu Lucy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,333
+21.89%
|
-
|
|
Jan 01
2024
|
Malcolm Hoenlein Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,333
+7.87%
|
-
|
|
Jan 01
2024
|
Dov Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,666
+9.51%
|
-
|
|
Jan 01
2024
|
J Jay Lobell Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,666
+5.45%
|
-
|
|
Jan 01
2024
|
Kevin Lorenz Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,333
+12.06%
|
-
|
|
Jan 01
2024
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
216,465
+7.14%
|
-
|
|
Jan 01
2024
|
Eric K Rowinsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,666
+8.83%
|
-
|
|
Jan 01
2024
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
216,465
+13.85%
|
-
|
|
Jan 01
2024
|
Jimmie Harvey Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,666
+8.7%
|
-
|
|
Dec 20
2023
|
David Jin Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+37.24%
|
-
|
|
Nov 14
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
1,567,515
+37.64%
|
$1,567,515
$1.7 P/Share
|
|
Nov 14
2023
|
Michael S Weiss Director |
BUY
Open market or private purchase
|
Direct |
147,058
+11.51%
|
$147,058
$1.7 P/Share
|
|
Sep 26
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
100,000
+0.64%
|
$0
$0.28 P/Share
|
|
Aug 18
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
10,000
+8.16%
|
$90,000
$9.34 P/Share
|
|
Aug 17
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
10,000
+8.89%
|
$110,000
$11.75 P/Share
|
|
Feb 10
2023
|
Lu Lucy Director |
BUY
Open market or private purchase
|
Direct |
11,976
+8.24%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
J Jay Lobell Director |
BUY
Open market or private purchase
|
Direct |
299,401
+15.47%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
2,395,209
+13.5%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
Eric K Rowinsky Director |
BUY
Open market or private purchase
|
Direct |
11,976
+1.27%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
Michael S Weiss Director |
BUY
Open market or private purchase
|
Direct |
1,197,604
+7.51%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
David Jin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
35,928
+2.44%
|
$0
$0.84 P/Share
|
|
Jan 01
2023
|
Jimmie Harvey Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.52%
|
-
|
|
Jan 01
2023
|
Malcolm Hoenlein Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+8.54%
|
-
|
|
Jan 01
2023
|
Dov Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+10.52%
|
-
|
|
Jan 01
2023
|
J Jay Lobell Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+6.96%
|
-
|
|
Jan 01
2023
|
Kevin Lorenz Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+13.71%
|
-
|
|
Jan 01
2023
|
Eric K Rowinsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.8%
|
-
|
|
Jan 01
2023
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,219,294
+8.25%
|
-
|
|
Jan 01
2023
|
Lu Lucy Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+29.17%
|
-
|
|
Jan 01
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,219,294
+8.6%
|
-
|
|
Dec 16
2022
|
Lu Lucy Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+29.58%
|
-
|
|
Dec 01
2022
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
100,000
+0.85%
|
$0
$0.68 P/Share
|
|
Nov 30
2022
|
David Jin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.36%
|
$0
$0.56 P/Share
|
|
Nov 30
2022
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
5,000
+0.04%
|
$0
$0.56 P/Share
|
|
Oct 26
2022
|
David Jin Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,350,000
+49.13%
|
-
|
|
Oct 21
2022
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
100,000
+0.85%
|
$0
$0.7 P/Share
|
|
Jun 01
2022
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
4,264
+0.04%
|
$0
$0.73 P/Share
|
|
Jan 01
2022
|
Eric K Rowinsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+10.87%
|
-
|
|
Jan 01
2022
|
J Jay Lobell Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+7.49%
|
-
|